AMPH · Company research
Amphastar Pharmaceuticals, Inc. (AMPH): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 25.91 | $1,184,760,330 | 961146330.00 | 9.260760743117002 | — | 1.9756289585316271 | 6.4423110552845794 | 1.5423413833370001 | 26.56770709063999641197 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.